SERCA control of cell death and survival
ER Chemaly, L Troncone, D Lebeche - Cell calcium, 2018 - Elsevier
Abstract Intracellular calcium (Ca 2+) is a critical coordinator of various aspects of cellular
physiology. It is increasingly apparent that changes in cellular Ca 2+ dynamics contribute to …
physiology. It is increasingly apparent that changes in cellular Ca 2+ dynamics contribute to …
The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease
SJ House, M Potier, J Bisaillon, HA Singer… - Pflügers Archiv-European …, 2008 - Springer
Abstract Calcium (Ca 2+) is a highly versatile second messenger that controls vascular
smooth muscle cell (VSMC) contraction, proliferation, and migration. By means of Ca 2+ …
smooth muscle cell (VSMC) contraction, proliferation, and migration. By means of Ca 2+ …
Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis
JL Johnson - Cardiovascular research, 2014 - academic.oup.com
After a period of relative senescence in the field of vascular smooth muscle cell (VSMC)
research with particular regards to atherosclerosis, the last few years has witnessed a …
research with particular regards to atherosclerosis, the last few years has witnessed a …
Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure
L Lipskaia, ER Chemaly, L Hadri… - Expert opinion on …, 2010 - Taylor & Francis
The cardiac isoform of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA2a) plays a
major role in controlling excitation/contraction coupling. In both experimental and clinical …
major role in controlling excitation/contraction coupling. In both experimental and clinical …
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
Cardiovascular diseases are a major cause of human death worldwide. Excessive
proliferation of vascular smooth muscle cells contributes to the etiology of such diseases …
proliferation of vascular smooth muscle cells contributes to the etiology of such diseases …
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
RJ Hajjar, K Zsebo, L Deckelbaum, C Thompson… - Journal of cardiac …, 2008 - Elsevier
BACKGROUND: Heart failure (HF) remains a major cause of morbidity and mortality in North
America. With an aging population and an unmet clinical need by current pharmacologic …
America. With an aging population and an unmet clinical need by current pharmacologic …
Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture
R Berra-Romani… - … of Physiology-Cell …, 2008 - journals.physiology.org
Phenotypic modulation of vascular myocytes is important for vascular development and
adaptation. A characteristic feature of this process is alteration in intracellular Ca2+ …
adaptation. A characteristic feature of this process is alteration in intracellular Ca2+ …
Cell proliferation, calcium influx and calcium channels
T Capiod - Biochimie, 2011 - Elsevier
Both increases in the basal cytosolic calcium concentration ([Ca2+] cyt) and [Ca2+] cyt
transients play major roles in cell cycle progression, cell proliferation and division. Calcium …
transients play major roles in cell cycle progression, cell proliferation and division. Calcium …
Therapeutic efficacy of AAV1. SERCA2a in monocrotaline-induced pulmonary arterial hypertension
Background—Pulmonary arterial hypertension (PAH) is characterized by dysregulated
proliferation of pulmonary artery smooth muscle cells leading to (mal) adaptive vascular …
proliferation of pulmonary artery smooth muscle cells leading to (mal) adaptive vascular …
Ca2+ Cycling and New Therapeutic Approaches for Heart Failure
AM Lompré, RJ Hajjar, SE Harding, EG Kranias… - Circulation, 2010 - Am Heart Assoc
Heart failure (HF) is a major health problem in Western countries. Despite significant
progress in pharmacological and device-based treatment, the disease burden imposed …
progress in pharmacological and device-based treatment, the disease burden imposed …